Low-level light treatment ameliorates immune thrombocytopenia
Immune thrombocytopenia (ITP) is an immune-mediated acquired bleeding disorder characterized by abnormally low platelet counts. We reported here the ability of low-level light treatment (LLLT) to alleviate ITP in mice. The treatment is based on noninvasive whole body illumination 30 min a day for a...
Main Authors: | Yang, Jingke, Zhang, Qi, Li, Peiyu, Dong, Tingting, Wu, Mei X |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/108825 |
Similar Items
-
CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.
by: Patrick J Mott, et al.
Published: (2013-01-01) -
Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia
by: Min Xu, et al.
Published: (2020-08-01) -
Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia
by: Mihnea-Alexandru Găman, et al.
Published: (2017-03-01) -
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
by: Shosaku Nomura
Published: (2016-01-01) -
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
by: Shosaku Nomura
Published: (2016-07-01)